Improving Efficacy of Endoscopic Diagnosis of Early Gastric Cancer: Gaps to Overcome from the Real-World Practice in Vietnam

Table 1

Questionnaire regarding esophagogastroduodenoscopy preparation, modalities, annual volume, and endoscopic diagnosis of gastric cancer.

---

(1) Your hospital name
(2) Your hospital type
 □ Central hospital
 □ Province hospital
(3) What is the average annual volume of esophagogastroduodenoscopy (EGD) at your hospital?
 □ 10.000–<30.000
 □ 30.000–60.000
 □ >60.000–100.000
(4) How often is the preprocedure preparation of EGD with oral simethicone?
 □ None
 □ Selective
 □ Routine
(5) How often does the endoscopy unit at your hospital apply chromoendoscopy during EGD?
 □ None
 □ Selective
 □ Routinely
(6) How often does the endoscopy unit at your hospital apply digital image-enhanced endoscopy during EGD?
 □ None
 □ Selective
 □ Routine
(7) Is magnifying endoscopy available in your hospital?
 □ Yes
 □ No
(8) Does your hospital have surveillance program for high-risk patients (i.e., patients with gastric dysplasia, intestinal metaplasia and moderate/severe gastric atrophy)?
 □ Yes
 □ No
(9) Have you documented any cases of early gastric cancer at your hospital over the last 10 years?
 □ Yes
 □ No
(10) Types of early gastric cancer according to the Japanese classification of gastric carcinoma: kindly number the following type from 1 (for the most common type) to 5 (for the least common type) and 0 for types which have never been seen at your hospital during the last 10 years.
 □ 0-I
 □ 0-IIa
 □ 0-IIb
 □ 0-IIc
 □ 0-III
(11) Please provide the number of patients with gastric cancer detected by diagnostic EGD in 2018 at your hospital.
(12) Please provide the number of patients with early gastric cancer detected by diagnostic EGD in 2018 at your hospital.

---